Xencor (XNCR) Cash & Equivalents (2013 - 2026)

Xencor (XNCR) reported Cash & Equivalents of $14.2 million for Q1 2026, down 64.28% year-over-year from $39.7 million in Q1 2025, and down 73.79% quarter-over-quarter from $54.1 million in Q4 2025.

Xencor (XNCR) Cash & Equivalents (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash & Equivalents data on file, last reported at $14.2 million in Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $14.2 million, down 64.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 million (down 64.28% YoY), and the FY2025 annual result was $54.1 million, up 32.29% from the prior year.
  • Cash & Equivalents declined to $14.2 million in Q1 2026 per XNCR's latest filing, from $54.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $78.3 million in Q1 2022 and troughed at $14.2 million in Q1 2026.
  • A 5-year average of $44.7 million and a median of $44.4 million in 2025 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2025 and 2026: Cash & Equivalents surged 44.44% in 2025, then plunged 64.28% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $53.9 million in 2022, then fell by 0.28% to $53.8 million in 2023, then dropped by 24.01% to $40.9 million in 2024, then soared by 32.29% to $54.1 million in 2025, then sank by 73.79% to $14.2 million in 2026.
  • Business Quant data shows XNCR's Cash & Equivalents at $14.2 million in Q1 2026, $54.1 million in Q4 2025, and $28.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Xencor 953.38 Mn 878.64 Mn - 14.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.17 Mn
Dec 31, 2025 54.07 Mn
Sep 30, 2025 28.29 Mn
Jun 30, 2025 44.44 Mn
Mar 31, 2025 39.68 Mn
Dec 31, 2024 40.88 Mn
Sep 30, 2024 29.03 Mn
Jun 30, 2024 30.77 Mn
Mar 31, 2024 31.03 Mn
Dec 31, 2023 53.79 Mn
Sep 30, 2023 52.73 Mn
Jun 30, 2023 34.71 Mn
Mar 31, 2023 72.39 Mn
Dec 31, 2022 53.94 Mn
Sep 30, 2022 52.65 Mn
Jun 30, 2022 49.41 Mn
Mar 31, 2022 78.27 Mn
Dec 31, 2021 143.48 Mn
Sep 30, 2021 41.20 Mn
Jun 30, 2021 115.84 Mn